Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
Background. The low prevalence of measles antibody in human immunodeficiency virus (HIV)-infected children after immune recovery as a result of highly active antiretroviral therapy increases the risk of morbidity and mortality from disease. The objective of our study was to evaluate the efficacy and...
Saved in:
Main Authors: | Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-34548215183&partnerID=40&md5=02e9b66b723df0d761645924f8b82375 http://www.ncbi.nlm.nih.gov/pubmed/17683001 http://cmuir.cmu.ac.th/handle/6653943832/2161 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: L. Aurpibul, et al.
Published: (2018)